第一单位：
Cancer Research Center of Lyon, Université de Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Centre Léon Bérard, "Cancer Immune Surveillance and Therapeutic Targeting" Team, 28 rue Laennec, Lyon 69008, France.;National Investigators Group for Ovarian and Breast Cancer Studies, GINEGEPS, Paris, France Department of Medical Oncology, Centre Léon Bérard, Lyon, France.
作者：
Olivia,Le Saux [1]
;
Renaud,Sabatier [2]
;
Isabelle,Treilleux [3]
;
Léa-Isabelle,Renaud [4]
;
Pierre-Emmanuel,Brachet [5]
;
Alejandra,Martinez [6]
;
Jean-Sébastien,Frenel [7]
;
Cyril,Abdeddaim [8]
;
Justine,Berthet [9]
;
Sarah,Barrin [10]
;
Amélie,Colombe-Vermorel [11]
;
Laetitia,Odeyer [11]
;
Alexandra,Lainé [12]
;
Christophe,Caux [9]
;
Bertrand,Dubois [9]
;
Isabelle,Ray-Coquard [13]
作者单位：
Cancer Research Center of Lyon, Université de Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Centre Léon Bérard, "Cancer Immune Surveillance and Therapeutic Targeting" Team, 28 rue Laennec, Lyon 69008, France.;National Investigators Group for Ovarian and Breast Cancer Studies, GINEGEPS, Paris, France Department of Medical Oncology, Centre Léon Bérard, Lyon, France.
[1]
Department of Medical Oncology, Institut Paoli Calmettes, CRCM, Aix-Marseille University, Inserm, CNRS, Marseille, France.;National Investigators Group for Ovarian and Breast Cancer Studies, Paris, France.
[2]
Biopathology Department, Centre Léon Bérard, GINECO, Lyon, France.;National Investigators Group for Ovarian and Breast Cancer Studies, Paris, France.
[3]
Department of Medical Oncology, Centre Léon Bérard, Lyon, France.
[4]
Department of Medical Oncology, Centre François Baclesse, Caen, France.
[5]
Department of Surgery, Institut Claudius Regaud, Institut Universitaire du Cancer de Toulouse, Toulouse, France.;National Investigators Group for Ovarian and Breast Cancer Studies, Paris, France.
[6]
Department of Medical Oncology, Institut de cancerologie de l'ouest site René Gauducheau, Saint Herblain, France.;National Investigators Group for Ovarian and Breast Cancer Studies, GINEGEPS, Paris, France.
[7]
Department of Gynecological Oncology, Centre de Lutte Contre le Cancer-Centre Oscar Lambret, Lille, France.
[8]
Cancer Research Center of Lyon, Université de Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Centre Léon Bérard, "Cancer Immune Surveillance and Therapeutic Targeting" Team, Lyon, France.;Lyon Immunotherapy for Cancer Laboratory, Cancer Research Center of Lyon, Centre Léon Bérard, Lyon, France.
[9]
Lyon Immunotherapy for Cancer Laboratory, Cancer Research Center of Lyon, Centre Léon Bérard, Lyon, France.
[10]
Biopathology Department, Centre Léon Bérard, GINECO, Lyon, France.
[11]
EMS Team, Centre Léon Bérard, Lyon, France.
[12]
National Investigators Group for Ovarian and Breast Cancer Studies, GINEGEPS, Paris, France.;Department of Medical Oncology, Centre Léon Bérard, Lyon, France.
[13]
DOI
10.1177/17588359251347364
PMID
40786594
发布时间
2025-08-13
换一批
